Article content
TORONTO The Canadian provinces of Quebec and New Brunswick will no longer offer first doses of the AstraZeneca COVID-19 vaccine, but will offer second doses using current supplies and future deliveries, the provinces said on Thursday.
Most provinces made similar announcements on Monday and Tuesday, mainly citing concerns about supply, though officials in Ontario, Nova Scotia and New Brunswick said the move was also based on a rise in the incidence of rare blood clots linked to first doses of the vaccine.
We apologize, but this video has failed to load.
Try refreshing your browser, or Quebec, New Brunswick stop offering first doses of AstraZeneca vaccine Back to video
Quebec, New Brunswick stop offering first doses of AstraZeneca COVID-19 vaccine Toggle share menu
Advertisement
Quebec, New Brunswick stop offering first doses of AstraZeneca COVID-19 vaccine
A medical worker fills a syringe with a vaccine at a COVID-19 vaccination center offering the AstraZeneca vaccine, as the number of the coronavirus disease infections decreases in Munich, Germany, May 13, 2021. REUTERS/Andreas Gebert
14 May 2021 05:08AM Share this content
Bookmark
TORONTO: The Canadian provinces of Quebec and New Brunswick will no longer offer first doses of the AstraZeneca COVID-19 vaccine, but will offer second doses using current supplies and future deliveries, the provinces said on Thursday (May 13).
Exempt GST on vaccine purchase: Naveen Patnaik writes to FM Sitharaman
Odisha to spend Rs 1,193 crore on purchase of vaccines; will save Rs 60 crore if GST waived.
Share Via Email
| A+A A- By Express News Service
BHUBANESWAR : Chief Minister Naveen Patnaik on Thursday requested the Centre for exemption of GST on purchase of Covid-19 vaccines and extend financial assistance to the states from the cess and surcharges to create an equal platform to fight the pandemic.
In a letter to the Union Finance Minister Nirmala Sitharaman, Naveen said that the states have been asked to purchase vaccines from their own resources to cover the 18 to 44 years age group. These purchases attract GST, making vaccines costly for the states. This needs to be exempted completely. It will reduce the cost for states and facilitate the drive towards universal vaccination, he stated.
Centre dismisses reports alleging non-procurement of COVID vaccines
Says released over Rs 1700 crore advance payment to Serum Institute for 11 crore Covishield jabs on April 28.
Share Via Email
| A+A A- By PTI
NEW DELHI: The Health Ministry on Monday said that 100 per cent advance of Rs 1732.50 crore was released to the Serum Institute of India on April 28 for 11 crore doses of Covishield vaccine during May, June and July.
The amount, which after TDS was Rs 1699.50 crore, was received by the SII on April 28 itself, it said.
As on date, against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses have been delivered till May 3, the ministry said, adding, media reports alleging that the Centre has not placed any fresh order for COVID-19 vaccines are incorrect and not based on facts .
›Full advance of over Rs 1,700 cr released to SII for 11 cr doses of Covishield on April 28: Govt
Full advance of over Rs 1,700 cr released to SII for 11 cr doses of Covishield on April 28: Govt
SECTIONS
Full advance of over Rs 1,700 cr released to SII for 11 cr doses of Covishield on April 28: GovtPTI
Last Updated: May 03, 2021, 03:29 PM IST
Share
Synopsis
As on date, against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses have been delivered till May 3, the ministry said, adding, media reports alleging that the Centre has not placed any fresh order for COVID-19 vaccines are incorrect and not based on facts .